All News


All series


All All News

The Food and Drug Administration (FDA) has granted the investigational BTK inhibitor zanubrutinib (BGB-3111) a breakthrough therapy designation for the treatment of adult patients with mantle cell lymphoma (MCL) who have previously received at least one prior therapy, according to BeiGene, the company manufacturing the agent.

As cancer once again robbed me of the chance to make the holiday memories I had hoped for, it took a kid eating frozen pizza on Christmas Eve to remind me what really mattered.

I often joke in training classes on aging that with every new candle on my birthday cake, a new medicine bottle shows up in my cabinet.

The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Making peace with radiation can be a challenge, even if high doses of targeted radiation can silence cancer cells. It took me almost two weeks to tame the beast of fear. What have you done to trick yourself into handling difficult situations during cancer treatment?